Thermo Fisher launches new test to assess lung transplant rejection
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase III IMforte study
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Subscribe To Our Newsletter & Stay Updated